ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 689529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 689529; 2) Community: the network communities that were significantly associated with the response to NSC 689529; 3) Molecule: the relationships between components within communities and NSC 689529; 4) MDR: the compounds that were significantly associated with the NSC 689529.

NSC Compound Enrichment Correlation
NSC 154948 M-AMSA 0.0135588245836371 0.43162667
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0135588245836371 0.40076419
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0135588245836371 0.33134986
NSC 18805 .gamma.-Thujaplicine 0.0135588245836371 0.47736131
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0135588245836371 0.24695099
NSC 244404 Null 0.0135588245836371 0.2637575
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0135588245836371 0.038013935
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0135588245836371 0.33218992
NSC 300289 Pinafide 0.0135588245836371 0.47110985
NSC 335995 Null 0.0135588245836371 -0.087790628
Total:145  Current:46    [First] [Prev] [Next] [Last]